glp-1 osteoporosis New Research on GLP-1s & Bone Health 🦴 ​A new large-scale study has raised questions about the long-term effects of receptor agonists (like Ozempic and Wegovy). While these medications are revolutionary An abstract and headline (not

We treat obesity as the medical condition it is

The price stays the same at every dose, and for an uninsured shopper planning to titrate up, that is the one variable that most often decides your real annual cost

A recent real-world study from Virta Health found that individuals with type 2 diabetes who discontinued GLP-1 therapy while continuing a ketogenic or low-carb diet maintained their weight loss over 12 months, with more than 70% sustaining at least 5% weight loss

Beyond WL, these effects may be partly driven by its triple agonism, particularly glucagon receptor activation, which enhances lipid oxidation and reduces hepatic lipid synthesis [56]

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide found in human plasma, saliva, and urine

In diet-induced MASLD rodent models, hepatic CAT enzymatic activity showed a non-significant difference as compared to respective standard chow diet-fed animals (Jung and Kim 2013